Carregant...
Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
The prevalence and economic burden of atrial fibrillation (AF) are predicted to more than double over the next few decades. In addition to anticoagulation and treatment of concomitant cardiovascular conditions, early and standardized rhythm control therapy reduces cardiovascular outcomes as compared...
Guardat en:
| Publicat a: | Cardiovasc Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208749/ https://ncbi.nlm.nih.gov/pubmed/33982075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvab153 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|